DiagnostykaFRA:7JS +1.17%19 OCF Yield % is 9.10 as of Jul. 05, 2026, which is 1% above its 10-year median of 9.04. GuruFocus rates FRA:7JS with a GF Score™ of 19/100. The stock has 1 warning sign investors should review. Among 215 Medical Diagnostics & Research companies, Diagnostyka ranks better than 82.79% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Diagnostyka's OCF Yield % or its related term are showing as below:
FRA:7JS'
s OCF Yield % Range Over the Past 10 Years
Min: 6.94 Med: 9.04 Max: 11.01
Current: 9.1
During the past 5 years, the highest OCF Yield % of Diagnostyka was 11.01%. The lowest was 6.94%. And the median was 9.04%.
FRA:7JS's OCF Yield % is ranked better than 82.79% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.99
vs FRA:7JS: 9.10
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Diagnostyka OCF Yield % Related Terms
Diagnostyka OCF Yield % Historical Data
* Premium members only.
The historical data trend for Diagnostyka's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Diagnostyka's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostyka OCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Diagnostyka's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Diagnostyka's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnostyka (FRA:7JS) has a OCF Yield % of 9.10 as of Jul. 05, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Diagnostyka and its competitors. This is near median its historical median of 9.04. Over the past decade, Diagnostyka's OCF Yield % has ranged from 6.94 to 11.01. According to the industry distribution chart, Diagnostyka ranks #37 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 17.2%.
Is Diagnostyka's OCF Yield % too high?
Diagnostyka's current OCF Yield % of 9.10 is near median its 10-year median of 9.04. Over the past 10 years, this metric has ranged from a low of 6.94 to a high of 11.01. The Medical Diagnostics & Research industry median OCF Yield % is 0.99. Diagnostyka's value of 9.10 is 819.2% above this industry median. Based on the distribution chart, Diagnostyka ranks #37 out of 215 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Diagnostyka has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Diagnostyka's OCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Diagnostyka ranks #37 out of 215 companies for OCF Yield %. This places Diagnostyka in the top 17% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 0.99. Diagnostyka's value of 9.10 is 819.2% above this benchmark. Historically, Diagnostyka's own OCF Yield % has ranged from 6.94 to 11.01 over the past decade. While the company's 10-year median is 9.04 vs. the industry median of 0.99, Diagnostyka has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Diagnostics & Research company?
The median OCF Yield % among Medical Diagnostics & Research companies is 0.99, based on 215 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diagnostyka's current OCF Yield % of 9.10 is 819.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Diagnostyka and its competitors. For the Medical Diagnostics & Research industry, the median OCF Yield % is 0.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnostyka's current OCF Yield % is 9.10, which is near median its own 10-year median of 9.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostyka stock overvalued right now?
Diagnostyka (FRA:7JS) has a current OCF Yield % of 9.10. The current OCF Yield % is 9.10, which is near median its 10-year median of 9.04 and 819.2% above the Medical Diagnostics & Research industry median of 0.99. Diagnostyka's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Diagnostyka (FRA:7JS), the current OCF Yield % is 9.10 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Diagnostyka SA is engaged in providing laboratory diagnostics services in Poland. The company offers comprehensive laboratory services from collecting biological material, through testing, to providing results online.
19GF Score
Get the complete analysis for FRA:7JS
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7JS has been successfully added to your 
